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Abstract Here we describe modified syntheses of o-acetylbenzoic
acids and o-acetylphenylacetic acids by Heck palladium-catalysed aryl-
ation of n-butyl vinyl ether with o-iodobenzoic acids or with o-iodo-
phenylacetic acids, respectively. General syntheses of benzo[b]naph-
tho[2,3-b]furan-6,11-diones from o-acetylbenzoic acids and 2-benzyl-
3-hydroxynaphthalene-1,4-diones from o-acetylphenylacetic acids are
also reported.
Key words fused-ring systems, Heck reaction, quinones, palladium,
heterocycles, halides, furans
The synthesis of naphthoquinones is of great signifi-
cance because of the widespread occurrence of the 1,4-
naphthoquinone nucleus in numerous natural and synthet-
ic compounds of biological and industrial interest.1–8 Spe-
cifically, considerable attention has been devoted to 2-hy-
droxy-1,4-naphthoquinones (I) and 2-hydroxy-3-phenyl-
1,4-naphthoquinones (II) (Figure 1), on account of their bi-
ological properties, their industrial applications, and their
potential as intermediates in the synthesis of oxygenated





carbazolequinones (III, Figure 1) became important syn-
thetic targets once their antineoplastic activity was estab-
lished.15–18 On the other hand, a representative example of
benzofuronaphthoquinones is compound IV (Figure 1) and
a representative example of benzopyronaphthoquinones V
(Figure 1) is the quinonoid anticoccidial antibiotic WS-
5995-A.19–21 The antineoplastic activity displayed by com-
pounds III, IV and V has been related to the well-known an-
titumor properties of ellipticine (Figure 1).15–18 The anti-
neoplastic activity of these compounds has been attributed
to their ring systems, which contain an embedded 2-
phenylnaphthalene-like structure in a planar conformation,
which facilitates its intercalation between adjacent pairs of
DNA bases, thereby interfering with DNA replication and
transcription.22 In addition, the quinone moiety present in
the ring skeleton explains the cytotoxic properties of these
compounds and enhances the strength of intercalative
binding to DNA through the formation of charge-transfer
interactions with the electron-rich DNA bases.23–25
Figure 1  Representative 2-hydroxy-1,4-naphthoquinones and tetracy-
clic naphthoquinones related to ellipticine
From a chemical point of view, particular interest has
been devoted to 2-hydroxy-3-phenyl-1,4-naphthoquinones
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VII, VIII and IX, and related compounds.15–18 Accordingly, a
range of methods for the preparation of these powerful
scaffolds have been developed, including our previously re-
ported general syntheses from o-acetylphenylacetic acids
XI (route a)26 and from o-acetylbenzoic acids XII (route b).27
Route a was found to be of limited scope because it only al-
lowed benzocarbazolequinones III to be prepared. These
tetracyclic naphthoquinones were alternatively obtained
through route b, by a sequence involving the condensation
of isochroman-1,4-diones XII with p-nitrobenzaldehydes,
followed by rearrangement of the resulting 3-benzylidene-
isochroman-1,4-diones XIII (X = NO2) to the corresponding
naphthoquinones (m = 0) and subsequent generation of the
nitrogen ring.28,29 These two general approaches to benzo-
carbazolequinones allowed the limitations of previous syn-
theses of these targets to be overcome.10,11,30–32 As a contin-
uation of this work, herein we report studies on the synthesis
of benzofuronaphthoquinones VII and benzopyronaphtho-
quinones VIII from o-acetylbenzoic acids XI, via 3-hydroxy-
2-phenylnaphthoquinones VI (Scheme 1). The synthesis of
2-benzyl-3-hydroxynaphthalene-1,4-diones (VI, m = 1) and
o-acetylphenylacetic acids X is also described.
Our previous, general and straightforward synthesis o-
acetylbenzoic acids involved a Heck coupling reaction be-
tween electron-rich n-butyl vinyl ether (BVE) and 2-bro-
mobenzoates 1a–b, using the conditions described by Cabri
et al.33 (Scheme 2).27 Firstly, a Heck reaction between BVE
and methyl o-bromobenzoate (1a) provided the expected
α-arylation product 2a only. This regiochemical outcome
was attributed to the presence of TlOAc and a chelating
phosphine in the reaction medium. The aryl vinyl ether 2a
was immediately reacted with 10% aqueous HCl for 1 hour
at room temperature, to afford ketoester 3a in 90% yield. On
the other hand, the coupling reaction between the elec-
tron-rich methyl 2-bromo-4,5-dimethoxybenzoate dime-
thoxy derivative 1b and BVE, under the same conditions,
gave ketoester 3b in lower yield, via aryl vinyl ether 2b.
Surprisingly, the same regioselectivity was observed
when the coupling reaction of 1a and 1b with BVE was per-
formed under classical Heck conditions, which required
longer reaction times, but avoided the use of toxic thallium
salts and expensive phosphines. The uncommonly high α-
regioselectivity achieved under these classical conditions
may be the result of an interaction between the o-carbome-
thoxy group of aryl halides 1 and the palladium complex
involved in the Heck coupling.
Scheme 1  Retrosynthetic plan towards benzofuronaphthoquinones VII, benzopyronaphthoquinones VIII and 2-hydroxy-3-benzyl-1,4-naphothoqui-
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Scheme 2  Heck coupling of methyl o-iodobenzoates 1c,d and methyl o-iodophenylacetates 1g,h and with BVE: synthesis of methyl o-acetylbenzoates 




















2a:  R = H (n = 0)
2b:  R = OMe (n = 0)
2c:  R = H (n = 1)
2d:  R = OMe (n = 1)
3a:  R = H (n = 0)
3b:  R = OMe (n = 0)
3c:  R = H (n = 1)
3d:  R = OMe (n = 1)
1a:  R = H, X = Br  (n = 0), 1b:  R = OMe, X = Br  (n = 0)
1c:  R = H, X = I (n = 0), 1d:  R = OMe, X = I  (n = 0)
1e:  R = H, X = Br  (n = 1), 1f:  R = OMe, X = Br  (n = 1)
1g:  R = H, X = I  (n = 1), 1h:  R = OMe, X = I (n = 1)Georg Thieme Verlag  Stuttgart · New York — SynOpen 2017, 1, 156–165
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were previously achieved for the coupling of o-bromophe-
nylacetates 1e and 1f with BVE, both under the Cabri and
classical conditions. o-Acetylphenylacetates 3c and 3d were
obtained respectively, via the corresponding enol ethers 2c
and 2d.
The similar reaction of BVE with methyl iodobenzoates
1c–d, and with methyl iodophenylacetates 1g–h was then
studied under these classical conditions, in order to assess
the influence of the halogen on this Heck coupling reaction.
A selective α-arylation was again observed, similar reaction
times were required, and similar yields were achieved (Ta-
ble 1, entries 1,2 and 3,4).
A tentative explanation for the role played by the carbo-
methoxy group of both types of substrates (1a–d or 1e–h)
in the Heck reaction is depicted in Scheme 3. The insertion
of Pd(0) into the carbon–halogen bond of the starting aryl
halide would lead to complex B, via complex A. Dissociation
of the halogen atom should give a cationic complex C, with
internal association of the methoxycarbonyl group. Remov-
al of a ligand L provided a free position that can be used to
link a BVE unit. Next, the o-carbomethoxy group could as-
sist the insertion of Pd(0) through chelation (complex D).34
It has been proposed that chelation between the carbonyl
group and the palladium atom could play an important role
in promoting high regioselectivities.33 This may be support-
ed by the fact that the regioselectivity in Heck reactions is
dependent on the ionic versus neutral mechanisms pro-
posed for this reaction, and that branched alkenes are
mainly obtained from electron-rich alkenes, such as BVE,
under ionic mechanism conditions.35–38 The predominance
of electronic over steric effects is responsible for the regio-
selectivity observed in this reaction.
According to our synthetic plan, methyl o-acetylbenzo-
ate 3a was hydrolysed, by refluxing a solution of this ke-
toester and 20% aqueous H2SO4 under reflux for 2 h.39 This
afforded the corresponding benzoic acid lactol 4a in 95%
yield (Scheme 4), which readily provided bromomethyl lac-
tol 5a in 96% yield, upon treatment with bromine in acetic
acid/toluene. Finally, treatment of 5a with NaOAc in ethanol
gave isochroman-1,4-dione 6a in 98% yield.27,39 Ketoester
3b was similarly and efficiently converted into isochroman-
1,4-dione 6b via compounds 4b and 5b.
Reaction of isochroman-1,4-dione 6a with o-bromo-
benzaldehyde (7a) in ammonium acetate/acetic acid pro-
vided the new benzylideneisochroman-1,4-dione 8a in 81%
yield. Treatment of 8a with sodium methoxide in methanol
gave the known 3-bromophenyl-2-hydroxy-1,4-naphtho-
quinone 10a in 65% yield, through rearrangement of inter-
mediate 9a.11 A similar condensation of isochroman-1,4-di-
one 6b with 2-bromo-4,5-dimethoxybenzaldehyde (7b),
resulted in the formation of benzylideneisochroman-1,4-
dione 8b, which rearranged readily to the expected 3-bro-
mophenyl-2-hydroxy-1,4-naphthoquinone 10b. As qui-
nones 10a and 10b were previously converted into benzo-
furonaphthoquinones 11a and 11b, respectively,30,31,40 the
present approach constitutes a novel, general synthesis of
these tetracyclic quinones, that overcomes limitations of
our previous routes.
In an attempt to apply this synthetic strategy to the
preparation of 5H-dibenzo[c,g]chromene-5,7,12-triones,
when isochroman-1,4-dione 6a was reacted with o-me-
thoxycarbonylbenzaldehyde, under the same conditions as
for 8a, the expected benzylideneisochroman-1,4-dione 11
was obtained in 75% yield (Scheme 5). However, when this
compound was reacted with sodium methoxide in metha-
nol, the resulting compound was not the desired 3-me-
thoxycarbonyl-2-hydroxynaphthoquinone 15 that should
result from intermediate 12. Compound 14 was obtained in
70% yield. Probably, the favoured process is now the lactoni-
sation of enol 13 of intermediate 12.
Table 1  Formation of 3a,b and 3c,d
Entry Sub-
strate
Catalysta Solvent Time Product Yield (%)
1 1c Pd(OAc)2/Ph3P 
(7.5 mol%)
CH3CN 4 h 3a 90
2 1d Pd(OAc)2/Ph3P 
(10 mol%)
CH3CN 16 h 3b 84
3 1g Pd(OAc)2/Ph3P 
(2.5 mol%)
CH3CN 16 h 3c 68
4 1h Pd(OAc)2/Ph3P 
(2.5 mol%)
CH3CN 1 week 3d 60
a All the experiments were carried out at 100 °C.
b See ref.23
c See ref.22
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2-hydroxy-1,4-naphthoquinones have received consider-
ably less attention than the corresponding 3-phenyl 2-hy-
droxy-1,4-naphthoquinones. Its most significant compo-
nent is lapachol, a natural occurring phenolic compound
isolated from the bark of the lapacho tree, which possess
antitumor and antiparasitic properties.41–44 A family of
compounds structurally related to lapachol are 3-benzyl-2-
hydroxy-1,4-naphthoquinones, which were previously pre-
pared by alkylation of 2-hydroxy-1,4-naphthoquinones
with alkyl halides or by condensation with aldehydes. Thus,
alkylation of lawsone with benzyl chlorides, under basic
conditions, provided the 3-benzyl-2-hydroxy-1,4-naphtho-
quinones with a range of 38–43% yield.42,45 Thus 3-benzyl-
2-hydroxy-1,4-naphthoquinones were alternatively ob-
tained by condensation of lawsone with benzaldehydes, in
a range of 75–85% yield.46,47
As an additional contribution to this field, we report
here the synthesis of 3-benzyl-2-hydroxy-1,4-naphthoqui-
nones 20a–d from o-acetylphenylacetic acids 16a,b, which
were obtained by hydrolysis of the respective methyl o-
acetylphenylacetates 3c,d (Scheme 6). Thus, condensation
of o-acetylphenylacetic acid (16a) with benzaldehyde (7c)
provided the corresponding α,β-unsaturated derivative 17a
(50%), which, upon catalytic hydrogenation, gave o-phenyl-
propylphenylacetic acid 18a in high yield (93%). Subsequent
treatment of this ketoacid with t-BuOK in t-BuOH, resulted
in the unreported benzylnaphthoquinone 20a in 57% yield.
Reaction of 17a with 3,4-dimethoxybenzaldehyde (7d) pro-
vided the unknown benzylnaphthoquinone 20b in 72%
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nylacetic acid 16b with benzaldehyde gave the known 3-
benzylnaphthoquinone 20c, via compounds 17c and 18c.
Finally, when 16b reacted with 3,4-dimethoxibenzalde-
hyde, the known benzylnaphthoquinone 20d was obtained
in 39% yield, via compounds 17d and 18d. This new synthe-
sis of 3-benzyl-2-hydroxy-1,4-naphthoquinones proved to
be more efficient than previously reported approaches.42,45
As a whole, we have revisited our general and efficient
method for the preparation of methyl o-acetylbenzoates
and methyl o-acetylphenylacetates. A slight modification
consisting of the replacement of the starting o-bromoben-
zoic acid esters and the o-bromophenylacetic acid esters by
the corresponding aryl iodides, allow these ketoacids to be
obtained in similar yields and stereoselectivities.
In addition, a new synthetic application of the o-acetyl-
benzoic acid derived isochroman-1,4-diones, involving
transformation into benzo[b]naphtho[2,3-b]furan-6,11-di-
ones was developed. This new, general synthesis of these
targets allows easy and efficient access to a variety of anti-
tumor quinones, for chemical and biological studies.
The practically unexplored o-phenylpropionylphenyl-
acetic acids are promising scaffolds for the development of
a range of further synthetic applications. Interestingly, the
2-benzyl-1,4-naphthoquinone nucleus is embedded in the
tetracyclic structures of benzo[b]acridine-6,11,12(5H)-tri-
ones48 and 11H-benzo[b]naphtho[2,3-e]pyran-6,11,12-tri-
ones.49 This structural relationship opens an opportunity
for a new synthetic approach to these targets, and provides
access to libraries of both practically unexplored kind of
compounds, for chemical and biological studies.
Work is in progress aimed at the exploration of these
promising chemical goals.
Melting points were determined with a Kofler Thermogerate appara-
tus and are uncorrected. Infrared spectra were recorded with a JASCO
FT/IR-400 spectrophotometer. Nuclear magnetic resonance spectra
were recorded, unless otherwise specified, with a Bruker WM-250
apparatus using CDCl3 solutions containing tetramethylsilane (TMS)
as internal standard. 1H NMR splitting patterns are designated as sin-
glet (s), doublet (d), triplet (t), quartet (q) or quintuplet (p). All first-
order splitting patterns were assigned based on the appearance of the
multiplet. Splitting patterns that could not be easily interpreted are
designated as multiplet (m) or broad (br). Mass spectra were obtained
with a HP 5988A mass spectrometer. Elemental analyses were per-
formed with an EA 1108 CHNS Fisons instrument. Thin-layer chroma-
tography (TLC) was performed using Merck GF-254 type 60 silica gel
and dichloromethane/methanol or EtOAc/hexane mixtures as elu-
ents; the TLC spots were visualised with ultraviolet light or iodine va-
pour. Column chromatography was carried out using Merck type
9385 silica gel. Solutions of extracts in organic solvents were dried
with anhydrous sodium sulphate.
Methyl 2-Acetylbenzoates and Methyl 2-(2-Acetylphenyl)acetates 
3; General Procedure
In a sealed tube fitted with Teflon screw cap, solutions of 1c, 1d, 1g
and 1h (1.2 mmol), BVE (0.09 mmol), Pd (OAc)2 (7.5%), PPh3 (0.18
mmol) and Et3N (0.90 mL) in anhydrous and deoxygenated CH3CN
(2.5 mL), were heated to 100 °C for 4 h. The respective reaction mix-
ture was filtered through Celite, washed with CH2Cl2, and the filtrates
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7c: R’ = H 
7d: R’ = OMe
17a: R = R’ = H (50%)
17b: R = H, R’ = OMe (95%)
17c: R = OMe, R’ = H (87%)
17d: R = R’ = OMe (not isolated)
18a: R = R’ = H (93%)
18b: R = H, R’ = OMe (87%)
18c: R = OMe, R’ = H (94%)
18d: R = R’ = OMe (58%)
20a: R = R’ = H (57%)
20b: R = H, R’ = OMe (72%)
20c: R = OMe, R’ = H (54%)
20d: R = R’ = OMe (39%)
3c: R = H 
3d: R = OMe
16a: R = H (92%)











19a: R = R’ = H 
19b: R = H, R’ = OMe
19c: R = OMe, R’ = H
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dried with anhydrous Na2SO4 and concentrated to dryness. The resi-
dues were dissolved in a mixture of 10% THF/HCl (40 mL, 1:1) and the
solution were stirred for 2 h at r.t., the solvent was evaporated and the
residues were extracted with CH2Cl2 (3 × 40 mL). The combined or-
ganic layers were washed with 10% aqueous NaHCO3, dried over an-
hydrous Na2SO4, and the solvent evaporated off. The residues were
purified by column chromatography (EtOAc/hexane, 2:3), to give 3a–
d.
Methyl 2-Acetylbenzoate (3a)50
Yield: 182 mg (90%); colourless oil.
IR: 1710 (C=O) cm–1.
1H NMR (CDCl3): δ = 2.53 (s, 3 H, CH3), 3.89 (s, 3 H, OCH3), 7.32–7.67
(m, 3 H, 3 × Ar-H), 7.77–7.92 (m, 1 H, Ar-H).
13C NMR (CDCl3): δ = 29.7 (CH3), 52.4 (OCH3), 126.4 (CH), 128.8 (C),
129.6 (CH), 130.0 (CH), 132.0 (CH), 142.6 (C), 167.4 (C=O), 202.8
(C=O).
MS: m/z (%) = 178 (100) [M+].
Methyl 2-Acetyl-4,5-dimethoxybenzoate (3b)
Yield: 186 mg (84%); white solid; mp 118–120 °C (EtOAc).
Methyl 2-(2-Acetylphenyl)acetate (3c)
Yield: 164 mg (68%); colourless oil.
Methyl 2-(2-Acetyl-4,5-dimethoxyphenyl)acetate (3d)
Yield: 128 mg (60%); white solid; mp 64–67 °C (Et2O).
IR (NaCl): 1703 (C=O), 1600 (C=O) cm–1.
1H NMR (CDCl3): δ = 2.58 (s, 3 H, CH3), 3.70 (s, 3 H, OCH3), 3.89 (s, 2 H,
CH2); 3.93 (s, 6 H, 2 × CH3), 6.72 (s, 1 H, Ar-H), 7.33 (s, 1 H, Ar-H).
13C NMR (CDCl3): δ = 28.5 (CH3), 40.2 (CH3), 51.8 (OCH3), 56.0 (OCH3),
56.2 (OCH3), 113.9 (CH), 115.5 (CH), 129.2 (C), 129.4 (C), 147.5 (Ar-
OCH3), 152.0 (Ar-OCH3), 172.2 (C=O), 199.1 (C=O).
MS: m/z (%) = 239 (21) [M+], 223 (100).
Anal. Calcd for C13H16O5: C, 61.90; H, 6.39. Found: C, 61.08; H, 6.19.
3-Hydroxy-3-methyl-3H-isobenzofuran-1-ones 4; General Proce-
dure
20% Aqueous H2SO4 (10 mL) was added to solutions of 3a and 3b (5.62
mmol) in dioxane (18 mL) and the reaction mixtures were heated at
reflux for 2 h. The mixtures were allowed to cool to r.t., poured into
water (20 mL) and extracted with CH2Cl2 (5 × 20 mL). The combined
organic layers were washed with water (2 × 20 mL), dried with anhy-
drous Na2SO4 and concentrated to dryness, to give 4a and 4b, respec-
tively.
3-Hydroxy-3-methyl-3H-isobenzofuran-1-ones (4a)
Yield: 0.88 g (95%); white solid; mp 116–118 °C (CHCl3).
IR (NaCl): 3267 (OH), 1726 (C=O) cm–1.
1H NMR (CDCl3): δ = 1.95 (s, 3 H, CH3), 5.71 (br s, 1 H, OH), 7.47–7.60
(m, 2 H, 2 × Ar-H), 7.63–7.82 (m, 2 H, 2 × Ar-H).
13C NMR (CD3OD): δ = 26.4 (CH3), 108.1 (C), 123.5 (CH), 125.9 (CH),
127.6 (C), 131.4 (CH), 135.8 (CH), 151.9 (C), 170.4 (C=O).
MS: m/z (%) = 165 (67) [M + H+], 147 (100).
Anal. Calcd for C9H8O3: C, 65.85; H, 4.91. Found: C, 65.98; H, 4.66.
3-Hydroxy-5,6-dimethoxy-3-methyl-3H-isobenzofuran-1-one (4b)
Yield: 1.04 g (98%); white solid; mp 143–145 °C (EtOAc).
IR (NaCl): 3378 (OH), 1719 (C=O) cm–1.
1H NMR (CDCl3): δ = 1.90 (s, 3 H, CH3), 3.90 (s, 3 H, OCH3), 3.98 (s, 3 H,
OCH3), 5.44 (br s, 1 H, OH), 6.96 (s,1 H, Ar-H), 7.15 (s, 1 H, Ar-H).
13C NMR (CDCl3): δ = 26.3 (CH3), 56.2 (OCH3), 56.3 (OCH3), 103.8 (CH,
C), 106.2 (CH), 117.9 (C), 143.8 (C), 150.8 (C), 154.7 (C), 169.0 (C=O).
MS: m/z (%) = 224 (29) [M+], 209 (100).
Anal. Calcd for C11H12O5: C, 58.93; H, 5.39. Found: C, 59.16; H, 5.26.
3-Bromomethyl-3-hydroxy-3H-isobenzofuran-1-ones 5; General 
Procedure
Bromine (1.2 mL, 23.4 mmol) was added dropwise, under stirring, to
solutions of lactols 4 and 4b (23.4 mmol) in a mixture of AcOH/tolu-
ene (1:2, 90 mL) heated at 60 °C. The reaction mixtures were stirred
for 30 minutes, evaporated to dryness, and the residues were crystal-
lised from CHCl3 to afford 5a and 5b, respectively.
3-Bromomethyl-3-hydroxy-3H-isobenzofuran-1-one (5a)
Yield: 5.46 g (96%); white solid; mp 115–117 °C (CHCl3).
IR (NaCl): 3260 (OH), 1752 (C=O) cm–1.
1H NMR (CDCl3): δ = 3.85 (d, J = 4.4 Hz, 2 H, CH2), 5.34 (br s, 1 H, OH),
7.55–7.84 (m, 4 H, 4 × Ar-H).
13C NMR (CDCl3, CD3OD): δ = 35.1 (CH2), 104.4 (C), 122.7 (CH), 125.2
(CH), 126.9 (C), 130.9 (CH), 134.6 (CH), 146.9 (C), 168.4 (C=O).
MS: m/z (%) = 245 (77) [M + H]+, 243 (80) [M + H]+, 227 (98), 225
(100).




Yield: 1.60 g (90%); white solid; mp 132–134 °C (CHCl3).
IR (NaCl): 3219 (OH), 1740 (C=O) cm–1.
1H NMR (CDCl3): δ = 3.84 (s, 2 H, CH2), 3.93 (s, 3 H, OCH3), 4.00 (s, 3 H,
OCH3), 7.07 (s, 1 H, Ar-H), 7.20 (s, 1 H, Ar-H).
13C NMR (CDCl3): δ = 36.2 (CH2), 56.4 (OCH3), 56.5 (OCH3), 103.1 (C-OH),
104.3 (CH), 106.1 (CH), 119.0 (C), 140.6 (C), 151.7 (C), 155.0 (C), 168.2
(C=O).
MS: m/z (%) = 304 (19) [M + H]+, 302 (20) [M + H]+, 223 (100).
Anal. Calcd for C11H11BrO5: C, 43.59; H, 3.66; Br, 26.36. Found: C,
43.86; H, 3.81.
Isochroman-1,4-diones 6; General Procedure
NaOAc (21.40 mmol) was added in portions to solution of 5a and 5b
(21.40 mmol) in EtOH (11 mL). The reaction mixtures were stirred at
r.t. for 30 min and then were concentrated to dryness, under vacuum.
The solids were washed with water and dried under vacuum to give
compounds 6a and 6b, respectively
Isochroman-1,4-dione (6a)36
Yield: 3.40 g (98%); white solid; mp 147–148 °C (CHCl3).
IR (NaCl): 1725 (C=O), 1695 (C=O) cm–1.
1H NMR (CDCl3): δ = 5.14 (s, 2 H, CH2), 7.82–7.95 (m, 2 H, 2 × Ar-H),
8.06–8.10 (m, 1 H, Ar-H), 8.25–8.29 (m, 1 H, Ar-H).Georg Thieme Verlag  Stuttgart · New York — SynOpen 2017, 1, 156–165
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131.7 (C), 134.6 (CH), 135.8 (CH), 161.4 (C=O), 189.4 (C=O).
Anal. Calcd for C9H9O3: C, 66.67; H, 3.73. Found: C, 61.03; H, 3.59.
6,7-Dimethoxyisochroman-1,4-dione (6b)
Yield: 1.18 g (95%); white solid; mp 253–255 °C (CHCl3).
IR (NaCl): 1714 (C=O), 1683 (C=O) cm–1.
1H NMR (CDCl3): δ = 4.04 (s, 3 H, OCH3), 4.06 (s, 3 H, OCH3), 5.11 (s,
2 H, CH2), 7.47 (s, 1 H, Ar-H), 7.66 (s, 1 H, Ar-H).
13C NMR (CDCl3): δ = 56.6 (OCH3), 56.8 (OCH3), 73.4 (CH2), 106.1 (CH),
111.4 (CH), 122.6 (C), 126.5 (C), 154.2 (C), 155.2 (C), 161.6 (C=O),
188.6 (C=O).
MS: m/z (%) = 222 (34) [M+], 164 (100).
Anal. Calcd for C11H10O5: C, 59.46; H, 4.54. Found: C, 59.67; H, 4.23.
3-Benzylidene-isochromane-1,4-diones 8; General Procedure
NH4OAc (209 mg, 2.71 mmol) was added to a solution of 6a and 6b
(1.23 mmol) and the respective aldehyde (1.23 mmol) in AcOH (5
mL), and the resulting solutions were heated at 60 °C for 6 h. The re-
action mixtures were allowed to cool to r.t., water (10 mL) was then
added and the precipitated solids were washed with water and dried,
to give 8a, 8b or 12.
3-(2-Bromobenzylidene)isochroman-1,4-dione (8a)
Yield: 988 mg (81%); yellow solid; mp 130–132 °C (MeOH).
IR (NaCl): 1746 (C=O) cm–1.
1H NMR (CDCl3): δ = 7.19–7.29 (m, 1 H, Ar-H), 7.38–7.46 (m, 1 H, Ar-
H), 7.58–7.69 (m, 2 H, =CH, Ar-H), 7.86–7.93 (m, 2 H, 2 × Ar-H), 8.24–
8.36 (m, 3 H, 3 × Ar-H).
13C NMR (CDCl3): δ = 118.1 (CH), 126.6 (C), 126.7 (C), 126.9 (CH),
127.7 (CH), 130.6 (CH), 131.2 (CH), 131.5 (C), 132.5 (CH), 133.1 (C),
133.2 (CH), 135.2 (2 × CH), 145.4 (C), 157.8 (C=O), 176.6 (C=O).
MS: m/z (%) = 328 (44) [M+], 330 (39) [M+], 249 (100).




Yield: 342 mg (85%); yellow solid; mp 289–290 °C (MeOH).
IR (NaCl): 1734 (C=O) cm–1.
1H NMR (CDCl3): δ = 3.94 (s, 3 H, OCH3), 4.00 (s, 3 H, OCH3), 4.07 (s,
6 H, 2 × OCH3), 7.12, 7.27, 7.58, 7.65, 8.08 (5s, 5 H, 4 × Ar-H, =CH).
MS: m/z (%) = 450 (10) [M+], 448 (10) [M+], 369 (100).
HRMS (ESI): m/z [M + H]+ calcd for C20H18BrO7: 449.0230; found:
449.0219.
3-(2-Carbomethoxybenzylidene)isochromane-1,4-dione (11)
Yield: 284 g (75%); yellow solid; mp 227–229 °C (MeOH).
IR (NaCl): 1763 (C=O) cm–1.
1H NMR (CDCl3): δ = 3.90 (s, 3 H, CH3), 7.42 (t, J = 7.5 Hz, 1 H, Ar-H),
7.59 (t, J = 7.5 Hz, 1 H, H-Ar), 7.81–7.91 (m, 3 H, H-C= and 2 × H-Ar),
7.96 (d, J = 7.7 Hz, 1 H, Ar-H), 8.07 (d, J = 7.7 Hz, 1 H, Ar-H), 8.19–8.31
(m, 2 H, 2 × Ar-H).
13C NMR (CDCl3): δ = 52.3 (CH3), 118.9 (CH=C), 126.7 (CH-Ar), 126.8
(C-Ar), 129.2 (CH-Ar), 130.4 (CH-Ar), 130.6 (CH-Ar), 131.7 (CH-Ar),
131.8 (C-Ar), 132.1 (CH-Ar), 132.2 (C-Ar), 133.1 (C-Ar), 135.0 (2 × CH),
144.7 (C=CH), 157.9 (CO), 167.1 (CO), 176.7 (CO).
MS: m/z (%) = 309.3 (53) [M + H]+, 174.2 (100) [M-C8H7O2].
HRMS (ESI): m/z [M + H]+ calcd for C18H13O5: 309.3702; found
309.3706.
2-Phenyl-3-hydroxynaphthalene-1,4-diones 10; General Proce-
dure
A solution of NaOMe (56.7 mg, 1.05 mmol) in MeOH (15 mL) was add-
ed dropwise to stirred solutions of benzylideneisochromane-1,4-di-
one 8a and 8b (0.5 mmol) in MeOH (20 mL) cooled at 0 °C. The result-
ing solutions were stirred for 24 h at r.t., poured into water (15 mL)
and acidified with aqueous 1 M HCl. The mixtures were extracted
with CH2Cl2 (3 × 10 mL) and the combined organic layers were dried
with anhydrous Na2SO4 and concentrated to dryness under vacuum.
The residues were purified by recrystallisation from MeOH, to yield
10a, 10b or 15.
2-(2-Bromophenyl)-3-hydroxy-1,4-naphthoquinone (10a)
Yield: 325 mg (65%); red solid; mp 172–174 °C (MeOH).
IR (NaCl): 3425 (OH), 1675 (C=O), 1641 (C=O) cm–1.
1H NMR (CDCl3): δ = 7.24–7.31 (m, 2 H, 2 × Ar-H), 7.37–7.45 (m, 1 H,
Ar-H), 7.66–7.85 (m, 3 H, 3 × Ar-H), 8.15–8.21 (m, 2 H, 2 × Ar-H).
13C NMR (CDCl3): δ = 122.6 (C), 123.9 (C), 126.3 (CH), 127.1 (CH),
127.3 (CH), 129.3 (C), 130.1 (CH), 131.4 (CH), 131.8 (C), 132.7 (C, CH),
133.2 (CH), 135.4 (CH), 152.7 (C), 181.6 (C=O), 182.7 (C=O).
MS: m/z (%) = 331 (95) [M + H]+, 329 (100) [M + H]+.




Yield: 170 mg (85%); red solid; mp 222–224 °C (MeOH).
3-(2-Carbomethoxybenzoyl)-1H-isochromen-1-one (14)
Yield: 690 mg (70%); red solid; mp 139–141 °C (MeOH/CH2Cl2).
IR (NaCl): 1765 (CO) cm–1.
1H NMR (CDCl3): δ = 3.79 (s, 3 H, CH3), 7.33 (s, 1 H, Ar-H), 7.41–7.49
(m, 1 H, H-Ar); 7.55–7.72 (m, 4 H, H-C= and 3 × Ar-H), 7.77 (t,
J = 7.5 Hz, 1 H, Ar-H), 8.07 (d, J = 7.7 Hz, 1 H, Ar-H), 8.31 (d, J = 7.7 Hz,
1 H, Ar-H).
13C NMR (CDCl3): δ = 52.6 (CH3), 110.5 (CH=C), 122.7 (C-Ar), 127.9
(CH-Ar), 128.1 (CH-Ar), 129.4 (C-Ar), 130.0 (C-Ar), 130.5 (CH-Ar),
131.8 (CH-Ar), 130.7 (CH-Ar), 132.2 (CH-Ar), 132.8 (CH-Ar), 135.1 (C-
Ar), 139.4 (CH-Ar), 149.6 (C = CH), 160.4 (CO), 166.3 (CO), 189.3 (CO).
MS: m/z (%) = 309 (65) [M + H]+, 174 (100) [M-C8H7O2].
HRMS (ESI): m/z [M + H]+ calcd for C18H13O5: 309.3523; found:
309.3525.
o-Acetylphenylacetic Acids 17; General Procedure
20% Aqueous sulphuric acid (3.5 mL) was added, under nitrogen, to a
solution of compounds 3c and 3d (1.56 mmol) in dioxane (9.0 mL)
and the mixtures were heated at reflux for 4 h. The reaction mixtures
were added over 10% aqueous NaOH (2 × 15 mL) and extracted with
Et2O (10 mL). The aqueous extracts were cooled at 0 °C and 20% H2SO4Georg Thieme Verlag  Stuttgart · New York — SynOpen 2017, 1, 156–165
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(3 × 20 mL). The combined extracts were washed with water (15 mL),
dried with anhydrous Na2SO4 and concentrated to dryness under vac-
uum, to give residues that were purified by recrystallisation, to afford
compounds 17a or 17b.
2-(2-Acetylphenyl)acetic Acid (16a)
Yield: 255 mg (92%); mp 135 °C (MeOH).
IR (NaCl): 3440 (COOH), 1707 (C=O), 1671 (C=O) cm–1.
1H NMR (CDCl3, CD3OD): δ = 2.50 (s, 3 H, CH3), 3.81 (s, 2 H, CH2), 4.23
(s, 1 H, COOH), 7.17 (d, J = 7.3 Hz, 1 H, Ar-H), 7.29–7.41 (m, 2 H,
2 × Ar-H), 7.73 (d, J = 7.5 Hz, 1 H, Ar-H).
13C NMR (CDCl3): δ = 28.3 (CH3), 39.9 (CH3), 127.8 (CH), 132.0 (CH),
132.5 (CH), 134.3 (C), 136.93 (C), 173.8 (C=O), 202.4 (C=O).
MS: m/z (%) = 178 (13) [M+], 160 (28), 135 (85), 132 (100).
Anal. Calcd for C10H10O3: C, 67.41; H, 5.66. Found: C, 67.26; H, 5.78.
2-(2-Acetyl-4,5-dimethoxyphenyl)acetic Acid (16b)
Yield: 461 mg (86%); mp 172–173 °C (MeOH).
IR (NaCl): 3020 (COOH), 1730 (C=O), 1638 (C=O) cm–1.
1H NMR (CDCl3, CD3OD): δ = 2.60 (s, 3 H, CH3), 3.87 (s, 3 H, CH3), 3.97
(s, 6 H, 2 × OCH3), 6.78 (s, 1 H, Ar-H), 7.35 (s, 1 H, Ar-H).
13C NMR (CDCl3, CD3OD): δ = 28.2 (CH3), 40.2 (CH3), 55.7 (OCH3), 55.9
(OCH3), 113.5 (CH), 115.1 (CH), 128.6 (C), 129.5 (C), 147.0 (Ar-OCH3),
151.8 (Ar-OCH3), 173.7 (C=O), 200.3 (C=O).
MS: m/z (%) = 238 (13) [M+], 185 (39), 179 (100).
Anal. Calcd for C12H14O5: C, 60.50; H, 5.92. Found: C, 60.23; H, 6.12.
Methyl 2-(2-Cinnamoylphenyl)acetates 17; General Procedure
15% Aqueous KOH (2 mL) was added to stirred solutions of 16a and
16b (0.90 mmol) and the appropriate aldehyde (1.10 mmol) in EtOH
(5 mL). The mixtures were heated at reflux for 45 min, cooled and
acidified with 10% aqueous HCl (10 mL). The suspensions were ex-
tracted with CHCl3 (3 × 15 mL). The combined extracts were washed
with water (3 × 15 mL), dried with anhydrous Na2SO4 and concentrat-
ed to dryness under vacuum, to give a yellow oil, that were dissolved
in MeOH (20 mL). A catalytic amount of p-toluensulphonic acid was
added and the mixtures were stirred at r.t. for 1.5 days. The reaction
mixtures were concentrated under vacuum and the remaining oils
were purified by flash column chromatography, using CH2Cl2 as elu-
ent, to provide 17a–d.
Methyl 2-(2-Cinnamoylphenyl)acetate (17a)
Yield: 127 mg (50%); colourless oil.
IR (NaCl): 1735 (C=O), 1723 (C=O), 1662 (C=O), 1636 (C=O) cm–1.
1H NMR (CDCl3): δ = 3.63 (s, 2 H, CH2), 3.90 (s, 3 H, OCH3), 7.20–7.50
(m, 7 H, Ar-H), 7.53–7.70 (m, 1 H, Ar-H).
13C NMR (CDCl3): δ = 38.9 (CH3), 51.8 (OCH3), 125.3 (CH), 126.96 (CH),
128.3 (2 × CH), 128.8 (2 × CH), 128.9 (CH), 130.5 (Ar-H), 131.0 (CH),
132 (CH), 133.7 (C), 134.4 (C), 138.44 (C), 145.7 (CH), 171.7 (C=O),
194.7 (C=O).
MS: m/z (%) = 280 (6) [M+], 220 (100).
Anal. Calcd for C18H16O3: C, 77.12; H, 5.75. Found: C, 77.10; H, 5.83.
Methyl (E)-2-(2-(3-(3,4-dimethoxyphenyl)acryloyl)phenyl)acetate 
(17b)
Yield: 363 mg (95%); colourless oil.
IR (NaCl): 1734 (C=O); 1656 (C=O), 1632 (C=O) cm–1.
1H NMR (CDCl3, CD3OD): δ = 3.63 (s, 2.7 H, OCH3), 3.65 (s, 2.7 H,
OCH3), 3.87–3.92 (m, 9.5 H, 2 × CH2 +4 × OCH3), 6.70–6.90 (m, 2.3 H,
Ar-H), 7.00–7.19 (m, 3.5 H, Ar-H), 7.19–7.51 (m, 4.8 H, Ar-H), 7.53–
7.69 (m, 1.9 H, Ar-H).
13C NMR (CDCl3, CD3OD): δ = 38.8 (CH3), 51.8 (OCH3), 55.69 (OCH3),
55.7 (OCH3), 55.8 (OCH3), 55.8 (OCH3), 108.9 (CH), 109.7 (Ar-H), 110.9
(Ar-H), 111.0 (CH), 121.4 (CH), 123.2 (CH), 123.5 (CH), 124.7 (CH),
126.9 (CH), 127.4 (C), 127.8 (CH), 128.6 (CH), 128.9 (CH), 130.8 (CH),
131.9 (CH), 133.4 (C), 133.5 (C), 138.7 (C), 138.8 (C), 141.9 (CH), 146.0
(CH), 146.3 (CH), 149.0 (C), 149.1 (C), 150.2 (C), 151.3 (C), 171.7
(C=O), 194.8 (C=O), 194.9 (C=O).
MS: m/z (%) = 340 (22) [M+], 281 (26), 164 (24), 151 (100).
Anal. Calcd for C20H20O5: C, 70.58; H, 5.92. Found: C, 70.23; H, 6.17.
Methyl 2-(2-Cinnamoyl-4,5-dimethoxyphenyl)acetate (17c)
Yield: 184 mg (87%); colourless oil.
IR (NaCl): 1734 (C=O), 1655 (C=O).
1H NMR (CDCl3, CD3OD): δ = 3.68 (s, 3 H, CH3), 3.86 (s, 2 H, CH2), 3.92
(s, 3 H, OCH3); 3.95 (s, 3 H, OCH3), 6.82 (s, 1 H, Ar-H), 7.21–7.31 (m,
2 H, Ar-H), 7.39–7.43 (m, 3 H, Ar-H), 7.57–7.67 (m, 3 H, Ar-H).
13C NMR (CDCl3, CD3OD): δ = 39.1 (CH3), 51.9 (OCH3), 56.0 (OCH3),
56.2 (OCH3), 112.5 (CH), 114.8 (CH), 125.2 (CH), 128.4 (2 × CH), 128.9
(2 × Ar-H), 130.5 (Ar-H), 130.8 (C), 134.7 (C), 145.1 (Ar-H), 147.4 (Ar-
OCH3), 151.2 (Ar-OCH3), 173.1 (C=O), 193.1 (C=O).
MS: m/z (%) = 340 (13) [M+], 281 (100).
Anal. Calcd for C20H20O5: C, 70.58; H, 5.92. Found: C, 70.72; H, 5.61.
Methyl (E)-2-(2-(3-(3,4-Dimethoxyphenyl)acryloyl)-4,5-dime-
thoxyphenyl)acetate (17d)
This product was not isolated; it was directly used in the next step.
Methyl 2-(2-(3-Phenylpropanoyl)phenyl)acetates 18; General Pro-
cedure
A Raney-nickel H2O suspension (ca. 50% w/w) was added over de-
gassed solutions of 17a, 17b, 17c and 17d (0.45 mmol) in EtOAc (20
mL) and the resulting suspensions were purged with hydrogen and
stirred at 0 °C under hydrogen (1 atm) for 30 min, then at r.t. for a fur-
ther 30 min. Hydrogen was then removed by purging with nitrogen
and the metallic catalyst was filtered off over a Celite pad that was
washed with EtOAc. The solvents were removed under vacuum, to af-
ford the respective products 18a–d, as chromatographically pure oils.
Methyl 2-(2-(3-Phenylpropanoyl)phenyl)acetate (18a)
Yield: 121 mg (93%); colourless oil.
IR (NaCl): 1735 (C=O), 1682 (C=O) cm–1.
1H NMR (CDCl3): δ = 2.97–3.06 (m, 2 H, CH2), 3.23–3.31 (m, 2 H, CH2),
3.68 (s, 3 H, OCH3), 3.92 (s, 2 H, CH2), 7.15–7.38 (m, 7 H, Ar-H), 7.44
(dt, J = 1.15, 7.4 Hz, 1 H, Ar-H), 7.74 (dd, J = 1.4, 7.6 Hz, 1 H, Ar-H).
13C NMR (CDCl3): δ = 30.1 (CH2), 39.9 (CH2), 42.4 (CH2), 51.8 (OCH3),
126.0 (CH), 127.3 (CH), 128.3 (2 × CH), 128.4 (2 × CH), 129.0 (CH),
131.7 (CH), 132.6 (CH), 134.1 (C), 137.2 (C), 141.1 (C), 171.9 (C=O),
202.5 (C=O).
MS: m/z (%) = 282 (100) [M+].Georg Thieme Verlag  Stuttgart · New York — SynOpen 2017, 1, 156–165
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Methyl 2-(2-(3-(3,4-Dimethoxyphenyl)propanoyl)phenyl)acetate 
(18b)
Yield: 328, mg (87%); colourless oil.
IR (NaCl): 1734 (C=O), 1684 (C=O) cm–1.
1H NMR (CDCl3): δ = 2.97 (t, J = 7.5 Hz, 2 H, CH2), 3.25 (t, J = 7.5 Hz,
2 H, CH2), 3.48 (s, 3 H, OCH3), 3.86 (s, 3 H, OCH3), 3.87 (s, 3 H, CH3),
3.91 (s, 2 H, CH2), 6.78 (s, 3 H, Ar-H), 7.25 (d, J = 7.2 Hz, 1 H, Ar-H),
7.30–7.49 (m, 2 H, Ar-H), 7.75 (d, J = 7.5 Hz, 1 H, Ar-H).
13C NMR (CDCl3): δ = 29.6 (CH2), 39.7 (CH2), 42.5 (CH2), 51.7 (OCH3),
55.6 (OCH3), 55.7 (OCH3), 111.7 (CH), 111.6 (CH), 120.0 (CH), 127.2
(CH), 128.9 (Ar-H), 131.6 (CH), 132.5 (CH), 133.7 (C), 134.0 (C), 147.2
(Ar-OCH3), 148.7 (Ar-OCH3), 171.8 (C=O), 202.5 (C=O).
MS: m/z (%) = 342 (26) [M+], 151 (100).
Anal. Calcd for C20H22O5: C, 70.16; H, 6.48. Found: C, 70.35; H, 6.63.
Methyl 2-(4,5-Dimethoxy-2-(3-phenylpropanoyl)phenyl)acetate 
(18c)
Yield: 225 mg (94%); colourless oil.
IR (NaCl): 1733 (C=O), 1672 (C=O) cm–1.
1H NMR (CDCl3): δ = 2.98–3.07 (m, 2 H, CH2), 3.19–3.27 (m, 2 H, CH2),
3.70 (s, 3 H, OCH3), 3.86 (s, 3 H, OCH3), 3.89 (s, 2 H, CH2), 3.92 (s, 3 H,
OCH3), 6.72 (s, 1 H, Ar-H), 7.16–7.38 (m, 6 H, Ar-H).
13C NMR (CDCl3): δ = 39.4 (CH2), 40.1 (CH2), 42.2 (CH2), 51.8 (OCH3),
55.9 (OCH3), 56.1 (OCH3), 112.6 (CH), 115.3 (CH), 126.1 (CH), 128.4
(2 × CH), 128.5 (2 × Ar-H), 128.9 (C), 129.1 (C), 141.3 (C), 147.3 (CH),
151.6 (Ar-OCH3), 172.2 (C=O), 200.3 (C=O).
MS: m/z (%) = 342 (8) [M+], 209 (100).
Anal. Calcd for C20H22O5: C, 70.16; H, 6.48. Found: C, 70.45; H, 6.41.
Methyl 2-(2-(3-(3,4-Dimethoxyphenyl)propanoyl)-4,5-dimethoxy-
phenyl)acetate (18d)
Yield: 89 mg (58%); colourless oil.
IR (NaCl): 1735 (C=O), 1671 (C=O) cm–1.
1H NMR (CDCl3): δ = 2.97 (t, J = 7.4 Hz, 2 H, CH2), 3.22 (t, J = 7.4 Hz,
2 H, CH2), 3.71 (s, 3 H, OCH3), 3.80–3.97 (m, 14 H, 4 × OCH3+CH2),
6.70–6.90 (m, 4 H, Ar-H), 7.18–7.31 (m, 1 H, Ar-H).
13C NMR (CDCl3): δ = 30.0 (CH3), 40.0 (CH2), 42.4 (CH2), 51.7 (OCH3),
55.7 (OCH3), 55.7 (OCH3), 55.8 (OCH3), 56.0 (OCH3), 111.1 (CH), 111.7
(CH), 112.6 (CH), 115.2 (CH), 120.0 (CH), 128.9 (C), 129.0 (C), 133.8
(C), 147.2 (2 × Ar-OCH3), 148.7 (Ar-OCH3), 151.5 (Ar-OCH3), 172.0
(C=O), 200.3 (C=O).
MS: m/z (%) = 402 (63) [M+], 209 (73), 151 (100).
Anal. Calcd for C22H26O7: C, 65.66; H, 6.51. Found: C, 65.65; H, 6.66.
2-Benzyl-3-hydroxy-1,4-naphthalene-1,4-diones 20; General Pro-
cedure
t-BuOK (257 mg, 2.10 mmol) was added to stirred solutions of 18a,
18b, 18c and 18d (0.42 mmol) in anhydrous t-BuOH (5 mL) at 0 °C.
The resulting mixtures were heated at reflux for 1.5 h, then cooled
and poured into 10% aqueous HCl (10 mL). The new mixtures were
extracted with CHCl3 (3 × 15 mL) and the combined organic layers
were dried with anhydrous Na2SO4, and concentrated to dryness un-
der vacuum. The residues were purified by column chromatography
(1:3, EtOAc/hexane), to afford compounds 20a, 20b, 20c and 20d, re-
spectively.
2-Benzyl-3-hydroxynaphthalene-1,4-dione (20a)
Yield: 65, mg (57%); orange solid; mp 148–150 °C (MeOH/Et2O).
IR (NaCl): 3334 (OH), 1655 (C=O), 1640 (C=O) cm–1.
1H NMR (CDCl3): δ = 3.94 (s, 2 H, CH2), 7.13–7.28 (m, 3 H, Ar-H), 7.37–
7.41 (m, 2 H, Ar-H), 7.46 (s, 1 H, OH), 7.61–7.16 (m, 2 H, Ar-H), 8.03–
8.12 (m, 2 H, Ar-H).
13C NMR (CDCl3): δ = 29.1 (CH2), 123.0 (C), 126.1 (CH), 126.3 (CH),
126.9 (CH), 128.4 (2 × Ar-H), 129.2 (2 × CH), 129.3 (C), 132.7 (C),
132.9 (CH), 134.9 (Ar-H), 138.9 (C), 153.0 (CH), 181.6 (C=O), 184.3
(C=O).
MS: m/z (%) = 264 (100) [M+].
HRMS (ESI): m/z [M + H]+ calcd for C17H13O3: 265.0859; found:
265.0843.
2-(3,4-Dimethoxybenzyl)-3-hydroxynaphthalene-1,4-dione (20b)
Yield: 56 mg (72%); red solid; mp 160–162 °C (MeOH).
IR (NaCl): 3355 (OH), 1659 (C=O), 1638 (C=O) cm–1.
1H NMR (CDCl3): δ = 3.82 (s, 3 H, OCH3), 3.86 (s, 3 H, OCH3), 3.88 (s,
2 H, CH2), 6.75 (d, J = 8 Hz, 1 H, Ar-H), 6.92–6.96 (m, 2 H, Ar-H), 7.47
(s, 1 H, Ar-H), 7.63–7.77 (m, 2 H, Ar-H), 8.04–8.13 (m, 2 H, Ar-H).
13C NMR (CDCl3): δ = 28.6 (CH2), 55.8 (2 × OCH3), 111.8 (CH), 112.6
(CH), 121.1 (CH), 123.2 (C), 126.1 (CH), 126.9 (CH), 129.3 (C), 131.3
(C), 132.7 (C), 132.9 (CH), 134.9 (CH), 147.5 (C), 148.7 (C), 152.8 (C),
181.7 (C=O), 184.5 (C=O).
MS: m/z (%) = 324 (94) [M+], 293 (100), 138 (53).
HRMS (ESI): m/z [M + H]+ calcd for C19H17O5: 325.1071; found:
325.1089.
2-Benzyl-3-hydroxy-6,7-dimethoxynaphthalene-1,4-dione (20c)
Yield: 63 mg (54%); red solid; mp 148 °C (decomp).
IR (NaCl): 3341 (OH), 1638 (C=O) cm–1.
1H NMR (CDCl3): δ = 3.90 (s, 2 H, CH2), 3.98 (s, 3 H, OCH3), 4.00 (s, 3 H,
OCH3), 7.12–7.31 (m, 4 H, 4 × Ar-H), 7.35–7.41 (m, 2 H, Ar-H+OH),
7.45 (s, 1 H, Ar-H), 7.54 (s, 1 H, Ar-H).
13C NMR (CDCl3): δ = 29.0 (CH2), 55.5 (OCH3), 56.5 (OCH3), 107.6 (CH),
108.7 (CH), 121.7 (C), 123.4 (C), 126.2 (CH), 128.0 (C), 128.4 (2 × CH),
129.1 (2 × CH), 139.1 (C), 152.5 (C), 152.8 (C), 154.4 (C), 180.9 (C=O),
184.2 (C=O).
MS: m/z (%) = 324 (100) [M+].




Yield: 43 mg (39%); red solid; mp 180 °C (MeOH).
IR (NaCl): 3312 (OH), 1652 (C=O), 1646 (C=O) cm–1.
1H NMR (CDCl3): δ = 3.82 (s, 3 H, OCH3), 3.84 (s, 2 H, CH2), 3.86 (s, 3 H,
OCH3), 3.99 (s, 3 H, OCH3), 4.01 (s, 3 H, OCH3), 6.76 (d, J = 8.1 Hz, 1 H,
Ar-H), 6.90–6.98 (m, 2 H, Ar-H), 6.46 (s, 1 H, Ar-H), 7.55 (m, 2 H, Ar-
H).
13C NMR (CDCl3): δ = 28.5 (CH2), 55.8 (2 × OCH3), 56.4 (OCH3), 56.5
(OCH3), 107.5 (CH), 108.7 (CH), 111.0 (CH), 112.5 (CH), 121.0 (CH),
121.9 (C), 123.4 (C), 127.9 (C), 132.6 (C), 147.4 (C), 148.7 (C), 152.5
(C), 152.6 (C), 154.4 (C), 180.1 (C=O), 184.2 (C=O).
MS: m/z (%) = 384 (55) [M+], 353 (46), 138 (100).Georg Thieme Verlag  Stuttgart · New York — SynOpen 2017, 1, 156–165
165
J. C. Barcia et al. PaperSyn OpenHRMS (ESI): m/z [M + H]+ calcd for C21H21O7: 385.1282; found:
385.1276.
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